Shop All Expression mRNA and Pre-Made Viruses

LentiArray™ CRISPR Positive Control Lentivirus, human HPRT (Invitrogen™)

Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system. The Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%. It can be used to rapidly determine ideal delivery conditions in order to achieve maximum editing efficiency in your cell model of choice.

LentiArray™ Human DNA Damage Response CRISPR Library (Invitrogen™)

The award-winning Invitrogen™ LentiArray™ Human DNA Damage Response Library targets 561 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 2,244 gRNAs. Libraries are delivered as 200 μL of ready to use lentiviral particles per gene target at a titer of 1x108 TU/mL (functional titer determined by antibiotic resistance) and are also available as glycerol stocks.

DNA surveillance proteins continuously monitor DNA integrity and activate cell cycle checkpoints and DNA repair pathways in response to DNA damage. The gene targets within this library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC).

Built to bring you success
LentiArray CRISPR libraries are constructed using gRNA designs produced using Thermo Fisher Scientific’s proprietary CRISPR gRNA design algorithm. This algorithm incorporates the latest gRNA design research, as well as our extensive in-house experience, to produce the highest quality designs. The gRNA designs included in the LentiArray CRISPR libraries are selected for maximal editing efficiency and specificity and are designed to knock out all known isoforms of the target gene. For each gene target, up to four high-quality gRNAs are included to help ensure highly efficient knockout of the target gene in a wide array of cell types.

Design and execute your experiments without limitations
LentiArray CRISPR libraries are designed and constructed to give you complete control over your experimental design. They utilize a two-vector design, expressing the Cas9 nuclease and the gRNA off of separate lentiviral constructs, enabling you to dictate when and how the genome editing tools are delivered to your cells.

The LentiArray Cas9 lentivirus construct expresses a human, codon-optimized Cas9 nuclease with a blasticidin-resistance gene under the control of the EF-1α (EFS) promoter. You can choose to co-infect your cells with both the LentiArray gRNA lentiviruses and the Cas9 lentivirus or just the LentiArray Cas9 lentivirus to establish a stable Cas9 expressing cell line. With LentiArray CRISPR libraries you have the freedom to design the experimental approach that best suits your model system and your screening goals.

Furthermore, to minimize restrictions to your experimental design, the gRNA lentiviruses that make up the LentiArray CRISPR libraries do not contain fluorescent markers. This allows reporters of any wavelength to be used with the libraries and expands your ability to perform multiplexed experiments. For challenging cell lines, the LentiArray gRNA lentiviruses contain a puromycin resistance gene that allows enrichment of the population of edited cells and drives stronger phenotypes.

Learn more about LentiArray CRISPR libraries >

Optimize your assay design and have full confidence in your results with LentiArray controls
High quality controls are the cornerstone of a successful screen. The LentiArray CRISPR libraries product line includes a suite of controls to help you quickly develop your assay and give you confidence in defining your hit criteria.

Learn more about LentiArray controls >

LentiArray™ CRISPR Positive Control Lentivirus, human HPRT, with GFP (Invitrogen™)

Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system. The Invitrogen™ LentiArray CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%. It can be used to rapidly determine ideal delivery conditions in order to achieve maximum editing efficiency in your cell model of choice. This construct also expresses emGFP to provide a visual readout of successful transduction that can be used in determining Multiplicity of Infection (MOI).

LentiArray™ CRISPR Negative Control Lentivirus, human, non-targeting (Invitrogen™)

Negative control gRNAs are essential in screening applications for setting thresholds for hit determination. The Invitrogen™ LentiArray™ CRISPR Negative Control Lentivirus, Human Scrambled, contains a gRNA sequence with no sequence homology to any region of the human genome.

LentiArray™ Human GPCR CRISPR Library (Invitrogen™)

The award-winning Invitrogen™ LentiArray™ Human GPCR Library targets 446 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 1,784 gRNAs. Libraries are delivered as 200 μL of ready to use lentiviral particles per gene target at a titer of 1x108 TU/mL (functional titer determined by antibiotic resistance) and are also available as glycerol stocks.

G protein-coupled receptors (GPCRs) are regulators of a wide range of physiological and disease processes. GPCRs have emerged as one of the most druggable classes of genes, with nearly 30% of FDA approved drugs targeting GPCRs. The gene targets within this library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC).

Built to bring you success
LentiArray CRISPR libraries are constructed using gRNA designs produced using Thermo Fisher Scientific’s proprietary CRISPR gRNA design algorithm. This algorithm incorporates the latest gRNA design research, as well as our extensive in-house experience, to produce the highest quality designs. The gRNA designs included in the LentiArray CRISPR libraries are selected for maximal editing efficiency and specificity and are designed to knock out all known isoforms of the target gene. For each gene target, up to four high-quality gRNAs are included to help ensure highly efficient knockout of the target gene in a wide array of cell types.

Design and execute your experiments without limitations
LentiArray CRISPR libraries are designed and constructed to give you complete control over your experimental design. They utilize a two-vector design, expressing the Cas9 nuclease and the gRNA off of separate lentiviral constructs, enabling you to dictate when and how the genome editing tools are delivered to your cells.

The LentiArray Cas9 lentivirus construct expresses a human, codon-optimized Cas9 nuclease with a blasticidin-resistance gene under the control of the EF-1α (EFS) promoter. You can choose to co-infect your cells with both the LentiArray gRNA lentiviruses and the Cas9 lentivirus or just the LentiArray Cas9 lentivirus to establish a stable Cas9 expressing cell line. With LentiArray CRISPR libraries you have the freedom to design the experimental approach that best suits your model system and your screening goals.

Furthermore, to minimize restrictions to your experimental design, the gRNA lentiviruses that make up the LentiArray CRISPR libraries do not contain fluorescent markers. This allows reporters of any wavelength to be used with the libraries and expands your ability to perform multiplexed experiments. For challenging cell lines, the LentiArray gRNA lentiviruses contain a puromycin resistance gene that allows enrichment of the population of edited cells and drives stronger phenotypes.

Learn more about LentiArray CRISPR libraries >

Optimize your assay design and have full confidence in your results with LentiArray controls
High quality controls are the cornerstone of a successful screen. The LentiArray CRISPR libraries product line includes a suite of controls to help you quickly develop your assay and give you confidence in defining your hit criteria.

Learn more about LentiArray controls >

LentiArray™ CRISPR Negative Control Lentivirus, human, non-targeting, with GFP (Invitrogen™)

Negative control gRNAs are essential in screening applications for setting thresholds for hit determination. The Invitrogen™ LentiArray™ CRISPR Negative Control Lentivirus, Human Scrambled, contains a gRNA sequence with no sequence homology to any region of the human genome. This construct also expresses emGFP to provide a visual readout of successful transduction that can be used in determining Multiplicity of Infection (MOI).

CytoTune™-iPS 2.0 Sendai Reprogramming Kit (Invitrogen™)

The CytoTune™-iPS 2.0 Sendai Reprogramming Kit improves upon the well-referenced CytoTune™-iPS Sendai Reprogramming Kit. Improvements in the 2.0 system include increased efficiency, lower cytotoxicity, and faster clearance in the generation of induced pluripotent stem cells. This system continues to be easy to use and works with many different somatic cell types, using Sendai particles to deliver Yamanaka factors, which have been shown to be critical for efficient generation of iPSCs. This kit includes three vector preparations: polycistronic Klf4–Oct3/4–Sox2, cMyc, and Klf4.

Features of the CytoTune™-iPS 2.0 Sendai Reprogramming Kit:

• Ease of use—still requires only one application of the virus to obtain successful reprogramming
• Increased efficiency—usually at least 2-fold higher reprogramming efficiencies than the original kit
• Rapid clearance—CytoTune™-iPS products use the non-integrating Sendai virus that remains in the cytoplasm, reducing the likelihood of integration into the host genome. With the CytoTune™-iPS 2.0 Sendai virus, the Sendai backbone and transgenes clear the cytoplasm faster than the original.

The CytoTune™-iPS 2.0 Sendai system continues to be one of the easiest methods available for cell reprogramming. Only one application of the virus is required, instead of the multiple days of transductions required for mRNA-mediated reprogramming. It is also an ideal system for blood cell reprogramming.

The CytoTune™-iPS 2.0 Sendai Reprogramming Kit typically exhibits greater than 2-fold efficiency over the original kit, for both fibroblast and blood reprogramming. Efficiencies greater than 1% have been obtained with both fibroblasts and blood cells. (BJ and CD34+ cells, respectively).

Please refer to each kit's Certificate of Analysis for the appropriate titer and volume recommendations for reprogramming.

LentiArray™ Human Whole Genome CRISPR Library (Invitrogen™)

The award-winning Invitrogen™ LentiArray™ Human Whole Genome Library targets 18,453 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 73,812 gRNAs. Libraries are delivered as 200 μL of ready to use lentiviral particles per gene target at a titer of 1x108 TU/mL (functional titer determined by antibiotic resistance) and are also available as glycerol stocks.

The LentiArray Human Whole Genome Library is ideal for whole genome surveys to identify novel targets in biological pathways and disease development. The gene targets within this library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC).

Built to bring you success
LentiArray CRISPR libraries are constructed using gRNA designs produced using Thermo Fisher Scientific’s proprietary CRISPR gRNA design algorithm. This algorithm incorporates the latest gRNA design research, as well as our extensive in-house experience, to produce the highest quality designs. The gRNA designs included in the LentiArray CRISPR libraries are selected for maximal editing efficiency and specificity and are designed to knock out all known isoforms of the target gene. For each gene target, up to four high-quality gRNAs are included to help ensure highly efficient knockout of the target gene in a wide array of cell types.

Design and execute your experiments without limitations
LentiArray CRISPR libraries are designed and constructed to give you complete control over your experimental design. They utilize a two-vector design, expressing the Cas9 nuclease and the gRNA off of separate lentiviral constructs, enabling you to dictate when and how the genome editing tools are delivered to your cells.

The LentiArray Cas9 lentivirus construct expresses a human, codon-optimized Cas9 nuclease with a blasticidin-resistance gene under the control of the EF-1α (EFS) promoter. You can choose to co-infect your cells with both the LentiArray gRNA lentiviruses and the Cas9 lentivirus or just the LentiArray Cas9 lentivirus to establish a stable Cas9 expressing cell line. With LentiArray CRISPR libraries you have the freedom to design the experimental approach that best suits your model system and your screening goals.

Furthermore, to minimize restrictions to your experimental design, the gRNA lentiviruses that make up the LentiArray CRISPR libraries do not contain fluorescent markers. This allows reporters of any wavelength to be used with the libraries and expands your ability to perform multiplexed experiments. For challenging cell lines, the LentiArray gRNA lentiviruses contain a puromycin resistance gene that allows enrichment of the population of edited cells and drives stronger phenotypes.

Learn more about LentiArray CRISPR libraries >

Optimize your assay design and have full confidence in your results with LentiArray controls
High quality controls are the cornerstone of a successful screen. The LentiArray CRISPR libraries product line includes a suite of controls to help you quickly develop your assay and give you confidence in defining your hit criteria.

Learn more about LentiArray controls >

LentiArray™ Cas9 Lentivirus (Invitrogen™)

LentiArray Cas9 Lentivirus provides an efficient method to drive high level Cas9 nuclease expression in a wide variety of cell types. The LentiArray Cas9 Lentivirus construct includes a human codon-optimized version of Cas9 with two nuclear localization signals to facilitate efficient delivery into the nucleus. The 100 µL size is sufficient for creating stable Cas9 expressing pools of cells or for isolating stable Cas9 expressing clones. LentiArray Cas9 Lentivirus is provided as ready to use lentivirus at a titer of 1 x 107 TU/mL.

BacMam LRRK2-GFP G2019S Reagent (Invitrogen™)

BacMam LRRK2-GFP G2019S Reagent is a modified insect cell virus (baculovirus) that enables easy, efficient, and titratable overexpression of full-length LRRK2-GFP G2019S in your choice of cellular background, including primary neurons and neuroblastoma cell lines.

BacMam LRRK2-GFP G2019S Reagent Lets You:

• Easily overexpress full-length LRRK2-GFP G2019S in most cellular backgrounds
• Visualize LRRK2 expression
• Conduct the LRRK2 cellular assays you need
• Understand the effects of therapeutically relevant LRRK2 mutations

Use BacMam Technology with GFP for Expression and Visualization of LRRK2
BacMam technology utilizes a modified baculovirus to deliver and express genes in mammalian cells with minimal effort and toxicity. It enables efficient, titratable LRRK2-GFP G2019S protein expression in various mammalian cellular backgrounds, including cell lines that may not be compatible with traditional transfection methods, such as primary neurons and neuroblastoma cell lines.

Expand Your Battery of Cellular Assays for LRRK2
Once full length LRRK2-GFP G2019S has been introduced into your cellular background, the transduced cells allow you the flexibility to conduct many types of LRRK2 experiments, including studies of regulation of physiologically functional pathways (including signaling pathways leading to function) and identification of potential physiological substrates for LRRK2.

Examine LRRK2 Mutations with BacMam Reagents
Use therapeutic mutant LRRK2-GFP G2019S along with the wild-type LRRK2-GFP (Cat No A14170) reagent to enable your research into LRRK2 mutations, including exploration of differences in cellular response to stimulus among different mutations. Use LRRK2-GFP to confirm LRRK2-GFP protein expression and compare localization of wild type with pathological mutants in various cell backgrounds, especially primary neurons.

For research use only. Not intended for human or animal therapeutic or diagnostic use.

Related Links:
LRRK2 tools for advancing Parkinson's disease research
Kinase protein portfolio
LanthaScreen® Eu Kinase Binding Assay
LanthaScreen® Activity Assay
Learn More About BacMam Technology

LentiArray™ Human Cell Surface CRISPR Library (Invitrogen™)

The award-winning Invitrogen™ LentiArray™ Human Cell Surface Protein Library targets 778 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 3,112 gRNAs. Libraries are delivered as 200 μL of ready to use lentiviral particles per gene target at a titer of 1x108 TU/mL (functional titer determined by antibiotic resistance) and are also available as glycerol stocks.

The broad array of cell surface proteins allows the cell to receive information from and react to its environment. The gene targets within this library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC).

Built to bring you success
LentiArray CRISPR libraries are constructed using gRNA designs produced using Thermo Fisher Scientific’s proprietary CRISPR gRNA design algorithm. This algorithm incorporates the latest gRNA design research, as well as our extensive in-house experience, to produce the highest quality designs. The gRNA designs included in the LentiArray CRISPR libraries are selected for maximal editing efficiency and specificity and are designed to knock out all known isoforms of the target gene. For each gene target, up to four high-quality gRNAs are included to help ensure highly efficient knockout of the target gene in a wide array of cell types.

Design and execute your experiments without limitations
LentiArray CRISPR libraries are designed and constructed to give you complete control over your experimental design. They utilize a two-vector design, expressing the Cas9 nuclease and the gRNA off of separate lentiviral constructs, enabling you to dictate when and how the genome editing tools are delivered to your cells.

The LentiArray Cas9 lentivirus construct expresses a human, codon-optimized Cas9 nuclease with a blasticidin-resistance gene under the control of the EF-1α (EFS) promoter. You can choose to co-infect your cells with both the LentiArray gRNA lentiviruses and the Cas9 lentivirus or just the LentiArray Cas9 lentivirus to establish a stable Cas9 expressing cell line. With LentiArray CRISPR libraries you have the freedom to design the experimental approach that best suits your model system and your screening goals.

Furthermore, to minimize restrictions to your experimental design, the gRNA lentiviruses that make up the LentiArray CRISPR libraries do not contain fluorescent markers. This allows reporters of any wavelength to be used with the libraries and expands your ability to perform multiplexed experiments. For challenging cell lines, the LentiArray gRNA lentiviruses contain a puromycin resistance gene that allows enrichment of the population of edited cells and drives stronger phenotypes.

Learn more about LentiArray CRISPR libraries >

Optimize your assay design and have full confidence in your results with LentiArray controls
High quality controls are the cornerstone of a successful screen. The LentiArray CRISPR libraries product line includes a suite of controls to help you quickly develop your assay and give you confidence in defining your hit criteria.

Learn more about LentiArray controls >

BacMam LRRK2 D1994A Reagent (Invitrogen™)

BacMam LRRK2 D1994A Reagent is a modified insect cell virus (baculovirus) that enables easy, efficient, and titratable overexpression of full-length D1994A LRRK2 (kinase-dead LRRK2 mutant) in your choice of cellular background, including primary neurons and neuroblastoma cell lines.

BacMam LRRK2 D1994A Reagent Lets You:

• Investigate LRRK2 mutation mechanisms and stimulus responses
• Assay LRRK2 relevance across a broad range of parameters
• Utilize most mammalian cellular backgrounds for LRRK2 overexpression

Examine LRRK2 Mutations with BacMam Reagents
Use of the BacMam LRRK2 therapeutic mutant reagents G2019S (Cat. no. A13389) and D1994A in addition to the wild-type LRRK2 reagent (Cat. no. A13388) enables you to research and determine LRRK2 mutant mechanisms. You can also evaluate the differences in cellular response to a stimulus among the different mutations.

Expand Your Battery of Cellular Assays for LRRK2
Once full length LRRK2 D1994A has been introduced into your cellular background, the transduced cells allow you the flexibility to conduct many types of LRRK2 research. Some examples include studying the regulation of physiologically functional pathways (including signaling pathways leading to function), or identification of potential physiological substrates for LRRK2.

Overexpress Full-Length LRRK2 in Most Mammalian Cell Backgrounds
BacMam technology utilizes a modified baculovirus to deliver and express genes in mammalian cells with minimal effort and toxicity. It enables efficient, titratable LRRK2 D1994A protein expression in various mammalian cellular backgrounds, including cell lines that may not be compatible with traditional transfection methods such as primary neurons and neuroblastoma cell lines.

For research use only. Not intended for any human or animal therapeutic or diagnostic use.

Related Links:
LRRK2 tools for advancing Parkinson's disease research
Kinase protein portfolio
LanthaScreen® Eu Kinase Binding Assay
LanthaScreen® Activity Assay
Learn More About BacMam Technology

LentiArray™ Human Ubiquitin CRISPR Library (Invitrogen™)

The award-winning Invitrogen™ LentiArray™ Human Ubiquitin Library targets 943 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 3,722 gRNAs. Libraries are delivered as 200 μL of ready to use lentiviral particles per gene target at a titer of 1x108 TU/mL (functional titer determined by antibiotic resistance) and are also available as glycerol stocks.

The ubiquitin system is integral to maintaining cellular homeostasis by regulating protein turnover. Dysregulation of the ubiquitin system has been linked to multiple diseases, including cancer, neurodegenerative, musculoskeletal, cardiovascular, and metabolic diseases, as well as being linked to viral infection. The gene targets within this library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC).

Built to bring you success
LentiArray CRISPR libraries are constructed using gRNA designs produced using Thermo Fisher Scientific’s proprietary CRISPR gRNA design algorithm. This algorithm incorporates the latest gRNA design research, as well as our extensive in-house experience, to produce the highest quality designs. The gRNA designs included in the LentiArray CRISPR libraries are selected for maximal editing efficiency and specificity and are designed to knock out all known isoforms of the target gene. For each gene target, up to four high-quality gRNAs are included to help ensure highly efficient knockout of the target gene in a wide array of cell types.

Design and execute your experiments without limitations
LentiArray CRISPR libraries are designed and constructed to give you complete control over your experimental design. They utilize a two-vector design, expressing the Cas9 nuclease and the gRNA off of separate lentiviral constructs, enabling you to dictate when and how the genome editing tools are delivered to your cells.

The LentiArray Cas9 lentivirus construct expresses a human, codon-optimized Cas9 nuclease with a blasticidin-resistance gene under the control of the EF-1α (EFS) promoter. You can choose to co-infect your cells with both the LentiArray gRNA lentiviruses and the Cas9 lentivirus or just the LentiArray Cas9 lentivirus to establish a stable Cas9 expressing cell line. With LentiArray CRISPR libraries you have the freedom to design the experimental approach that best suits your model system and your screening goals.

Furthermore, to minimize restrictions to your experimental design, the gRNA lentiviruses that make up the LentiArray CRISPR libraries do not contain fluorescent markers. This allows reporters of any wavelength to be used with the libraries and expands your ability to perform multiplexed experiments. For challenging cell lines, the LentiArray gRNA lentiviruses contain a puromycin resistance gene that allows enrichment of the population of edited cells and drives stronger phenotypes.

Learn more about LentiArray CRISPR libraries >

Optimize your assay design and have full confidence in your results with LentiArray controls
High quality controls are the cornerstone of a successful screen. The LentiArray CRISPR libraries product line includes a suite of controls to help you quickly develop your assay and give you confidence in defining your hit criteria.

Learn more about LentiArray controls >

LentiArray™ Human Druggable CRISPR Library (Invitrogen™)

The award-winning Invitrogen™ LentiArray™ Human Druggable Genome Library targets 10,132 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 40,512 gRNAs. Libraries are delivered as 200 μL of ready to use lentiviral particles per gene target at a titer of 1x108 TU/mL (functional titer determined by antibiotic resistance) and are also available as glycerol stocks.

The LentiArray Human Druggable Genome Library is ideal for identifying potential therapeutic targets involved in the development and progression of disease. The gene targets within this library were selected using the most up-to-date genome databases, including the NCBI RefSeq database, and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC).

Built to bring you success
LentiArray CRISPR libraries are constructed using gRNA designs produced using Thermo Fisher Scientific’s proprietary CRISPR gRNA design algorithm. This algorithm incorporates the latest gRNA design research, as well as our extensive in-house experience, to produce the highest quality designs. The gRNA designs included in the LentiArray CRISPR libraries are selected for maximal editing efficiency and specificity and are designed to knock out all known isoforms of the target gene. For each gene target, up to four high-quality gRNAs are included to help ensure highly efficient knockout of the target gene in a wide array of cell types.

Design and execute your experiments without limitations
LentiArray CRISPR libraries are designed and constructed to give you complete control over your experimental design. They utilize a two-vector design, expressing the Cas9 nuclease and the gRNA off of separate lentiviral constructs, enabling you to dictate when and how the genome editing tools are delivered to your cells.

The LentiArray Cas9 lentivirus construct expresses a human, codon-optimized Cas9 nuclease with a blasticidin-resistance gene under the control of the EF-1α (EFS) promoter. You can choose to co-infect your cells with both the LentiArray gRNA lentiviruses and the Cas9 lentivirus or just the LentiArray Cas9 lentivirus to establish a stable Cas9 expressing cell line. With LentiArray CRISPR libraries you have the freedom to design the experimental approach that best suits your model system and your screening goals.

Furthermore, to minimize restrictions to your experimental design, the gRNA lentiviruses that make up the LentiArray CRISPR libraries do not contain fluorescent markers. This allows reporters of any wavelength to be used with the libraries and expands your ability to perform multiplexed experiments. For challenging cell lines, the LentiArray gRNA lentiviruses contain a puromycin resistance gene that allows enrichment of the population of edited cells and drives stronger phenotypes.

Learn more about LentiArray CRISPR libraries >

Optimize your assay design and have full confidence in your results with LentiArray controls
High quality controls are the cornerstone of a successful screen. The LentiArray CRISPR libraries product line includes a suite of controls to help you quickly develop your assay and give you confidence in defining your hit criteria.

Learn more about LentiArray controls >

BacMam LRRK2 Reagent (Invitrogen™)

BacMam LRRK2 Wild Type Reagent is a modified insect cell virus (baculovirus) that enables easy, efficient, and titratable overexpression of full-length wild-type LRRK2 in your choice of cellular background, including primary neurons and neuroblastoma cell lines.

BacMam LRRK2 Wild Type Reagent Lets You:

• Easily overexpress full-length LRRK2 in most cellular backgrounds
• Conduct the LRRK2 cellular assays you need
• Understand the effects of therapeutically relevant LRRK2 mutations

Examine LRRK2 Mutations with BacMam Reagents
Use therapeutic mutant reagents G2019S (Cat. no. A13389) and D1994A (Cat. no. A13390) along with the wild-type LRRK2 reagent to enable your research into LRRK2 mutations, including exploration of differences in cellular response to stimulus among different mutations.

Expand Your Battery of Cellular Assays for LRRK2
Once full length LRRK2 has been introduced into your cellular background, the transduced cells allow you the flexibility to conduct many types of LRRK2 experiments, including studies of regulation of physiologically functional pathways (including signaling pathways leading to function), and identification of potential physiological substrates for LRRK2.

Overexpress Full-Length LRRK2 in Most Mammalian Cell Backgrounds
BacMam technology utilizes a modified baculovirus to deliver and express genes in mammalian cells with minimal effort and toxicity. It enables efficient, titratable LRRK2 protein expression in various mammalian cellular backgrounds, including cell lines that may not be compatible with traditional transfection methods, such as primary neurons and neuroblastoma cell lines.

For research use only. Not intended for any human or animal therapeutic or diagnostic use.

Related Links:
LRRK2 tools for advancing Parkinson's disease research
Kinase protein portfolio
LanthaScreen® Eu Kinase Binding Assay
LanthaScreen® Activity Assay
Learn More About BacMam Technology